“South Africa’s National Institute for Communicable Diseases (NICD) has reported a surge in diphtheria cases, with 37 confirmed infections and seven carriers identified across three provinces. Public health officials are intensifying vaccination drives, treatment protocols, and awareness campaigns to contain the outbreak.”
1. Background of the Outbreak
Diphtheria, a vaccine-preventable disease caused by Corynebacterium diphtheriae, has re-emerged in South Africa after years of low incidence. Between 29 December 2025 and 5 July 2026, the NICD confirmed 37 respiratory diphtheria cases and identified seven asymptomatic carriers. Most cases (84%) were concentrated in the Western Cape, with additional infections in Limpopo (11%) and Gauteng (5%).
2. Latest Developments
The week 27 situational report (10 July 2026) confirmed four new laboratory cases: two in Limpopo, one in Gauteng, and one in the Western Cape. No new carriers were detected. Public health teams have initiated contact tracing, chemoprophylaxis, and vaccination campaigns to prevent further spread.
3. Clinical Presentation
Symptoms of respiratory diphtheria include:
- Sore throat and low-grade fever
- Greyish-white adherent membrane in the throat or nose
- Swollen neck glands (“bull neck”)
- Severe complications such as myocarditis, neuropathy, and renal damage
These symptoms highlight the urgency of early detection and treatment.
4. Treatment and Management
- Antibiotics (azithromycin or penicillin) are administered to clear the bacteria and prevent transmission.
- Diphtheria antitoxin (DAT) is used to neutralize toxins; early administration is often life-saving.
- Supportive care includes airway management, oxygen therapy, ECG monitoring, and in severe cases, intubation or tracheostomy.
5. Public Health Response
Authorities have launched:
- Expanded vaccination campaigns targeting vulnerable populations.
- Awareness drives to educate communities about symptoms and prevention.
- Rapid response teams for outbreak containment in affected provinces.
The NICD emphasizes that vaccination remains the most effective prevention tool.
6. Challenges Facing South Africa
- Vaccine hesitancy in certain communities.
- Healthcare resource strain, as diphtheria cases add pressure to hospitals already managing influenza and RSV outbreaks.
- Geographic spread, with cases reported in multiple provinces, complicating containment efforts.
7. Regional and Global Context
Globally, diphtheria remains rare due to widespread immunization, but outbreaks occur in regions with low vaccination coverage. South Africa’s outbreak underscores the importance of sustained immunization programs and robust surveillance systems.
8. Expert Commentary
Public health experts warn that delayed treatment can be fatal, urging clinicians to administer DAT immediately when diphtheria is suspected. Epidemiologists stress that community-level vaccination campaigns are critical to halting transmission.
9. Looking Ahead
The NICD will continue weekly situational reporting to monitor case numbers and guide interventions. If vaccination uptake improves, officials expect the outbreak to stabilize within the next two months. However, without strong compliance, diphtheria could spread further, posing risks to unvaccinated populations.
✅ Conclusion
South Africa’s diphtheria outbreak is a stark reminder of the importance of routine immunization and rapid public health response. With four new cases confirmed this week, authorities are racing to contain the disease through vaccination, treatment, and awareness campaigns. Continued vigilance and community cooperation will determine whether the outbreak is swiftly controlled or escalates into a wider public health crisis.
